| SC | conditioned stimulus; sacrococcygeal; Sanitary Corps; scalenus [muscle]; scapula; Schwann cell; scia... |
|---|---|
| GTN | - Stages of GTN(FIGO, WHO) 1. Stage O; Molar Pregnancy(H-Mole... |
| MEN | Multiple Endocrine Neoplasia ; AD Trait 1. MEN Type I(= Wermer Syndro... |
| MLF | Median Longitudinal Fasciculus Role; links the CN III Nucleus with Contralateral CN ... |
| NYHA | New York Heart Association Heart Disease¿¡ ´ëÇÑ Functional Classification &nbs... |
| P-III-P | precollagen-III-peptide |
|---|---|
| FN III | fibronectin type III |
| HTLV-III/LAV | human T cell lymphotropic virus type III/lymphadenopathy associated virus |
| HTLV-III/LAV | human T lymphotrophic virus type III/lymphadenopathy-associated virus |
| PDE III | phosphodiesterase III |
| processus styloideus ossis metacarpalis III | A pointed projection from the dorsolateral angle of the base of the third metacarpal bone; it sometimes exists as a separate ossicle. Synonym: processus styloideus ossis metacarpalis III. (05 Mar 2000) |
|---|---|
| protoporphyrinogen type III | The immediate precursor of protoporphyrin III in haem biosynthesis; elevated in cases of variegate porphyria. (05 Mar 2000) |
| protoporphyrinogen type III oxidase | A mitochondrial enzyme that uses O2 to convert protoporphyrinogen type III to protoporphyrin type III in haem biosynthesis; a deficiency of this enzyme is associated with variegate porphyria. (05 Mar 2000) |
| protoporphyrin type III | 2,7,12,18-Tetramethyl-3,8-divinylporphin-13,17dipropionic acid;the principal protoporphyrin found in nature (one of 15 possible isomers), characterised by the presence of 4 methyl groups, 2 vinyl groups, and 2 propionic acid side chains; a porphyrin derivative that, with iron, forms the haem of haemoglobin and the prosthetic groups of myoglobin, catalase, cytochromes, etc. (05 Mar 2000) |
| Hind III | <enzyme, molecular biology> Commonly used type II restriction endonuclease isolated from Haemophilus influenzae, it cleaves the sequence AAGCTT between the two As thus generating sticky ends. (18 Nov 1997) |
| P site | <molecular biology> The peptidyl tRNA binding site on the ribosome, the one to which the growing chain is attached, the incoming aminoacyl tRNA attaches to the A site. (18 Nov 1997) |
| secondary site | A second site in which cancer is found. Example: cancer in the lymph nodes near the breast is a secondary site. (09 Oct 1997) |
| HTLV-III | <abbreviation> Human T-cell lymphotropic virus type III. See: human immunodeficiency virus. (05 Mar 2000) |
| sequence tagged site | <molecular biology> Short (200 to 500 base pairs) DNA sequence that has a single occurrence in the human genome and whose location and base sequence are known. Detectable by PCR, sequence tagged sites are useful for localising and orienting the mapping and sequence data reported from many different laboratories and serve as landmarks on the developing physical map of the human genome. Expressed sequence tags are sequence tagged sites derived from cDNAs. (11 Jun 1998) |
| sequence-tagged site map | A map representing the order and spacing of sequence-tagged sites within a stretch of DNA. (05 Mar 2000) |
| hyperlipoproteinaemia type III | A rather uncommon form of familial hyperlipaemia characterised by the presence of lipoproteins of abnormal composition. The main abnormal lipoproteins are called beta-vldl and have a different apoprotein content and a higher proportion of cholesterol relative to triglyceride than normal vldl. (12 Dec 1998) |
| hypersensitive site | <molecular biology> A short segment of DNA which is especially prone to being cleaved by endonuclease enzymes like DNase. These sites tend to be within gene promoter regions. (11 Jan 1998) |
| site | The spatial confines of a particular project. (09 Oct 1997) |
| site-directed mutagenesis | <molecular biology> Any of several methods used to create specific alterations in a gene. (09 Oct 1997) |
| site potential tree | A tree that has attained the average maximum height possible given site conditions where it occurs. (05 Dec 1998) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|